Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Our company/
  3. Social impact /
  4. Global health equity /
  5. Treating Children At Risk for Intestinal Worms

Treating children at risk for intestinal worms

Intestinal worms infections rob children of vital nutrients and a bright future. By donating deworming medication and supporting hygiene education programs, we are working toward a world where children learn and play, free of intestinal worms.

More from Johnson & Johnson

5 things we now know about bladder cancer

Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. Learn how Johnson & Johnson is helping to change the treatment landscape.

What are alloantibodies?

Learn how Johnson & Johnson is investigating a therapy for two alloantibody-driven diseases that can affect the lives of developing fetuses and newborn babies.

Meet two Johnson & Johnson nurse educators dedicated to teaching cancer care providers

Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 56 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.